MedTrace Logo

Assessment and Treatment of Patients With Long-term Dizziness in Primary Care

NCT02655575 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2025-02-05

No results posted yet for this study

Summary

Brief Summary:

The purpose of the present study is to examine the effects of a Group based intervention consisting of vestibular rehabilitation (VR) combined with cognitive behavioral therapy (CBT) in patients with long--lasting vestibular dizziness. The study also aims to describe sociodemographic, physical and psychological characteristics in the patients, and to examine prognostic factors related to functional status and disability following participation in the intervention.

Prior to the RCT, a feasibility study will be conducted to examine the feasibility of the study protocol.

Conditions

Interventions

BEHAVIORAL

BI + VR + CBT

Brief intervention (information and advice) + group-based vestibular rehabilitation combined with cognitive behavioral therapy

BEHAVIORAL

BI + phone calls

Brief intervention (information and advice). Patients are followed-up by phone calls

Sponsors & Collaborators

  • University of Bergen

    collaborator OTHER

  • Norwegian Fund for Postgraduate Training in Physiotherapy

    collaborator OTHER

  • University of Southern Denmark

    collaborator OTHER

  • Duke University

    collaborator OTHER

  • Haukeland University Hospital

    collaborator OTHER

  • Bergen University College

    lead OTHER

Principal Investigators

  • Gro AF Flaten, ph.d. · Bergen University College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02655575 on ClinicalTrials.gov